NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that Drew Fromkin, President and Chief Executive Officer will present at Collins Stewart’s 4th Annual Growth Conference at the New York Mandarin Hotel on Wednesday, July 9th at 1:30pm Eastern Time.
